WuXi Biologics (Cayman) Inc. (HKG:2269)
Hong Kong · Delayed Price · Currency is HKD 40.98
+1.38 (3.48%)
Sep 30, 2025, 4:08 PM HKT
WuXi Biologics Market Cap
WuXi Biologics has a market cap or net worth of 166.53 billion as of September 30, 2025. Its market cap has increased by 255.14% in one year.
Market Cap
166.53B
Enterprise Value
162.90B
Revenue
21.98B
Ranking
n/a
PE Ratio
37.83
Stock Price
40.98
Market Cap Chart
Since June 13, 2017, WuXi Biologics's market cap has increased from 32.04B to 166.53B, an increase of 419.79%. That is a compound annual growth rate of 21.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 30, 2025 | 166.53B | 130.97% |
| Dec 31, 2024 | 72.10B | -42.32% |
| Dec 29, 2023 | 124.99B | -50.53% |
| Dec 30, 2022 | 252.68B | -35.37% |
| Dec 31, 2021 | 390.94B | -6.90% |
| Dec 31, 2020 | 419.91B | 228.82% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Jun 13, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines AG | 279.26B |
| Hansoh Pharmaceutical Group Company | 210.92B |
| JD Health International | 206.50B |
| Innovent Biologics | 159.71B |
| Sino Biopharmaceutical | 142.12B |
| Akeso | 122.24B |
| Sichuan Kelun-Biotech Biopharmaceutical | 113.38B |
| CSPC Pharmaceutical Group | 103.93B |